The drug is FDA-approved to treat type 2 diabetes in adults
The combination of monthly dosing, a new indication category (neuroscience instead of cardiometabolic), and the broader GLP-1-and-addiction signal is the most interesting pipeline development in this class right now
Exercising is an opportunity to get stronger and give back to my body, so I never cut corners or just go through the motions
Advanced stacking options beyond the basic Wolverine protocol Once you understand the fundamentals, more sophisticated approaches become available
14 A randomized, double-blind, parallel-group, placebo-controlled, superiority trial comparing semaglutide 1.0 mg against placebo therapy as an adjunct to standard of care on kidney outcomes in people with type 2 diabetes and chronic kidney disease, the decision to discontinue the trial was based on a recommendation from the trials independent Data Monitoring Committee indicating an interim analysis of the kidney outcomes trial for weekly semaglutide had met certain prespecified criteria for stopping the trial early for efficacy
Metabolic Benefits In addition to weight loss, semaglutide has demonstrated metabolic benefits that make it appealing for individuals with obesity-related health conditions